AD GWAS Summary Statistics#
Summary statistics from large-scale Alzheimer’s disease GWAS used as primary trait input for fine-mapping, TWAS, and colocalization analyses in the FunGen-xQTL flagship study.
All summary statistics were harmonized to GRCh38 prior to downstream analyses. The APOE region (chr19:44.4–46.5 Mb) was handled separately due to its complex LD structure. A custom LD reference panel was constructed from 16,905 ADSP whole-genome sequenced samples of European ancestry.
Datasets#
Six datasets from four AD meta-analyses were used, encompassing clinically confirmed late-onset AD, proxy-based AD cases, and broader dementia phenotypes.
| Study | Population | N cases | N controls | Phenotype definition | Notes |
|---|---|---|---|---|---|
| Bellenguez et al. 2022 Nat Genet | European | 111,326 | 677,663 | Clinically confirmed late-onset AD | Primary GWAS; used throughout |
| Wightman et al. 2021 Nat Genet | European | 90,338 | 1,036,225 | AD + proxy-AD (UK Biobank) | Proxy-based phenotype included |
| Kunkle et al. 2019 Nat Genet | European | 21,982 | 41,944 | Clinically confirmed late-onset AD | ADGC/IGAP |
| Jansen et al. 2019 Nat Genet | European | — | — | AD + proxy-AD (UK Biobank) | Meta-analysis with IGAP |
| Lambert et al. 2013 Nat Genet | European | 17,008 | 37,154 | Clinically confirmed late-onset AD | IGAP stage 1; historical reference |
| Broader dementia phenotype | European | — | — | Broader dementia definition | Fourth meta-analysis source |
Quality Control#
Summary statistics were processed through a QC pipeline built around SLALOM, supplemented by manual curation comparing single-effect regression and conditional regression outputs to exclude suspicious or unstable loci. After QC, 170 AD-associated loci were retained for fine-mapping.
LD Reference Panel#
| Panel | N samples | Population | Build | Synapse ID |
|---|---|---|---|---|
| ADSP WGS | 16,905 | European ancestry | GRCh38 | syn69670651 → EUR/ (syn69670652) |
Data Access#
| Resource | Description | Synapse ID |
|---|---|---|
| ADSP LD reference (EUR) | Custom LD panel for fine-mapping and colocalization | syn69670652 |
| LDSC reference data | LD scores, munged GWAS, sLDSC annotations | syn69670653 |
| LDSC munged GWAS | Pre-munged AD GWAS summary statistics | syn69670656 |
| AD GWAS fine-mapping models | Fine-mapping outputs per GWAS dataset | syn69670625 |
| AD fine-mapping results | Fine-mapped loci and credible sets | syn69696846 |
| Top loci unified summary | AD_GWAS_finemapping_109_blocks_top_loci_unified_any0.8ANDmin0.5.csv.gz | syn69865824 |
All resources are in the FunGen-xQTL staging folder: syn68872650 (staging)
Abbreviations#
| Abbreviation | Full name |
|---|---|
| AD | Alzheimer’s disease |
| GWAS | Genome-wide association study |
| ADSP | Alzheimer’s Disease Sequencing Project |
| IGAP | International Genomics of Alzheimer’s Project |
| ADGC | Alzheimer’s Disease Genetics Consortium |
| LD | Linkage disequilibrium |
| WGS | Whole-genome sequencing |
| QC | Quality control |
| sLDSC | Stratified linkage disequilibrium score regression |